Published on September 22 2022

5th IPLESP seminar

COVID

Since January 2020, and the appearance of the SarsCov-2 pandemic, the IPLESP teams have engaged in research work on the new coronavirus in a wide range of fields: modeling, surveillance, population epidemiology, clinical epidemiology, therapeutic evaluation, and social epidemiology. This work has led to fruitful collaborations between the teams and their results have been communicated through webinars.

SUMO CLEPIVIR THERAVIR NEMESIS PEPITES

5th IPLESP seminar - research on COVID-19

Program :

Risk factors for mortality in patients hospitalized for Covid-19, Sophie Tezenas du Montcel, PEPITES team
Mental health effects of the covid-19 out break, Judith van der Waerden, ERES team
Serological follow-up of participants in the SAPRIS multi-cohort study - what lessons? Fabrice Carrat, CLEPIVIR team
Covivac-ID : Study of the humoral response to SARS CoV-2 variants and the cellular response after vaccination against COVID-19 in immunocompromised persons, Anne Geneviève Marcelin/ Valérie Pourcher, Equipe THERAVIR
Covid long round table: issues 3 questions, Mediator: Olivier Robineau